Alvotech
ALVO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
Other share classesALVOW
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
72
- +15 vs. Q1 2026
- Total value $157.44M
Superinvestors holding ALVO
1
- At the end of Q2 2026
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by ALVO insiders, newest first.
No open-market purchases or sales by ALVO insiders are on file.
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in ALVO at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rubric Capital Management LP | 15,677,093 | $57.85M | 0.53% | +15,677,093 | New |
| MILLENNIUM MANAGEMENT LLC | 4,263,644 | $15.73M | 0.01% | +2,141,048+100.9% | Added |
| Bracebridge Capital, LLC | 4,038,637 | $14.9M | 3.22% | +1,333,333+49.3% | Added |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,689,612 | $13.97M | 0.00% | +279,165+8.2% | Added |
| Farallon Capital Management, L.L.C. | 2,859,675 | $10.55M | 0.06% | +2,660,000+1,332.2% | Added |